as well as in Kemipharm S.A. (“Kemipharm”), a tablet and capsule manufacturer located in Morocco to Sun Pharma for approx. USD 31 million. The MBH team advising on the transaction was led by Omar S. Bassiouny (Founding Partner and Group Head of Corporate and M&A) and included Ossama Abouzaid (Counsel). Ascent Capital was also involved in the transaction as the financial advisor to Valstar Investment.  For more about Matouk Bassiouny, check out our website at https://matoukbassiouny.com/.

---